Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine

• Main Authors: Brian Baker (Author), Barbara Schaeffler (Author), Martin Beliveau (Author), Igor Rubets (Author), Susan Pederson (Author), MyMy Trinh (Author), Jeff Smith (Author), John Latham (Author)
• Format: Book
• Published: Wiley, 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Eptinezumab is a humanized mAb that targets calcitonin gene‐related peptide and is under regulatory review for the prevention of episodic and chronic migraine (EM, CM). It is important to determine whether exposures achieved with intravenous (IV) administration of eptinezumab achieve desire...